Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisa Giles Insider Profile
4 Followers
Lisa Giles, Director at GenMark, holds 0.00 shares in GenMark (Ticker: GNMK), holds ― shares in Milestone Pharmaceuticals (Ticker: MIST), holds 35.81K shares in HCW Biologics (Ticker: HCWB).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+39.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lisa Giles holds in companies
Most Profitable Insider Trade
Stock:
GenMark
(GNMK)
(GNMK)
Rating:Informative Buy
Date:Nov 04, 2015 - Nov 04, 2016
Return:+68.30%
The most profitable trade made by Lisa Giles
Lisa Giles's Trading History
GenMark
Apr 22, 2021
―
Uninformative Sell
2.09M
$0.00
Milestone Pharmaceuticals
―
Director
―
―
HCW Biologics
Feb 22, 2024
Director
Uninformative Buy
50.00K
$42.98K
Durata
Nov 18, 2014
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Lisa Giles's performance on stock
You May Also Like
Lisa Giles insider profile FAQ
What is the percentage of profitable transactions made by Lisa Giles?
The percentage of profitable transactions made by Lisa Giles is 100%.
What is the average return per transaction made by Lisa Giles?
The average return per transaction made by Lisa Giles is 39.00%.
What stocks does Lisa Giles hold?
Lisa Giles holds: GNMK, MIST, HCWB, DRTX stocks.
What was Lisa Giles’s latest transaction?
Lisa Giles latest transaction was an Uninformative Sell of $2.09M.
What was Lisa Giles's most profitable transaction?
Lisa Giles’s most profitable transaction was an Informative Buy of GNMK stock on November 4, 2015. The return on the trade was 68.30%.
What is Lisa Giles's role in GenMark?
Lisa Giles's role in GenMark is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.